Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety Study of MYOBLOC® Followed by Open-Label Multiple-Treatment With MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adult Subjects

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Seeking treatment for troublesome sialorrhea for at least 3 months that is occurring secondary to any disorder or related to any cause~* Investigator sites will review entire list of inclusion criteria with potential subjects~Exclusion Criteria:~* Any known prior exposure to botulinum toxin type B, or known adverse reaction or sensitivity to botulinum toxin type A, or known sensitivity to any of the MYOBLOC solution components.~* Prior botulinum toxin treatment to the salivary glands at any time~* Investigator sites will review entire list of exclusion criteria with potential subjects

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- MYOBLOC 2500 U (Type: ACTIVE_COMPARATOR): Subjects will receive specified dose of MYOBLOC
- MYOBLOC 3500 U (Type: ACTIVE_COMPARATOR): Subjects will receive specified dose of MYOBLOC
- Placebo (Type: PLACEBO_COMPARATOR): Subjects will receive volume matched Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).